MITF and melanoma: Furthermore, MITF is required for the survival of drug‐addicted resistant melanomas (Kong et al., 2017) and MITF upregulation is found in up to 23% of melanomas progressed on treatment (Smith et al., 2016; Van Allen et al., 2014).